Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

17.83
+0.03000.17%
Volume:577.76K
Turnover:10.34M
Market Cap:3.47B
PE:-35.61
High:18.28
Open:17.61
Low:17.56
Close:17.80
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:193.53M
Volume Ratio:1.82
T/O Rate:0.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:2.82
PE(LYR):-11.01

Loading ...

Legend Biotech Posts Preliminary $710 Million Quarterly Sales for CARVYKTI®

TIPRANKS
·
2 hours ago

Legend Biotech Says Carvykti Posts About $710 Million Net Trade Sales in Quarter Ended Sept. 30, 2026

Reuters
·
3 hours ago

Legend Biotech : Barclays Cuts Target Price to $68 from $74

THOMSON REUTERS
·
4 hours ago

Legend Biotech is Maintained at Neutral by JP Morgan

Dow Jones
·
Oct 10

Legend Biotech Corporation : JP Morgan Cuts Target Price to $33 from $35

THOMSON REUTERS
·
Oct 09

Legend Biotech Price Target Cut to $56.00/Share from $58.00 by RBC Capital

Dow Jones
·
Oct 08

RBC Trims Price Target on Legend Biotech to $56 From $58, Keeps Outperform Rating

MT Newswires Live
·
Oct 08

Coursera, PSEG, Nauticus, Legend, Arlo Insider Shock

TIPRANKS
·
Oct 03

Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says

MT Newswires Live
·
Oct 03

Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Legend Biotech (LEGN)

TIPRANKS
·
Oct 02

Legend Biotech Director Makes Bold Move With Fresh Insider Stock Sale

TIPRANKS
·
Oct 02

Legend Biotech Director Corazon D. Sanders Sells 27,370 Shares for $258,920.20

Reuters
·
Oct 02

Legend Biotech Launches Inaugural Elite Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma

THOMSON REUTERS
·
Oct 01

Legend Biotech Price Target Maintained with a $65.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 30

Legend Biotech Says Five-Year Carvykti Data Show 50% of Patients Remained Progression-Free and Alive

MT Newswires Live
·
Sep 25

Legend Biotech Reports Five-Year CARVYKTI Survival Data in Earlier-Line Myeloma

TIPRANKS
·
Sep 25

Legend Biotech Shareholders Back Board Slate and Expand Equity Plan at 2026 AGM

TIPRANKS
·
Sep 25

Legend Biotech Shareholders Voted at Annual General Meeting

Reuters
·
Sep 25

Legend Biotech CFO Makes a Notable Move With Fresh Insider Stock Sale

TIPRANKS
·
Sep 24

Legend Biotech CEO Ingrid Zhang Files Initial Beneficial Ownership Statement

Reuters
·
Sep 17